Global Point-of-Care Testing Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

  • Published On : 06-10-2017
  • Published By : Data Bridge Market Research
  • No. of Pages : 357 Pages

Global point-of-care testing market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.

Based on geography, the global point-of-care testing market is segmented into 5 geographical regions, such as,

North America,
South America,
Europe,
APAC,
MEA,
Rest Of the World
Global point-of-care testing market competition by top players including -
F. Hoffmann-La Roche Ltd is going to dominate the Point-Of-Care Testing market following with Siemens AG and Abbott Laboratories, Inc., along with others such as
Beckman Coulter, Inc.,
Becton, Dickinson and Company,
Johnson & Johnson, Alere Inc.,
 Instrumentation Laboratory,
PTS Diagnostics, Abaxis, Inc.,
Medtronic, Accriva Diagnostics,
OPTI Medical, Sienco, Inc.,
Alpha Scientific,
AccuBioTech Co., Ltd.,
ACON Laboratories, Inc.,
Acrongenomics, Inc.,
bioMérieux SA,
Biomerica, Inc.,
Atlas Genetics Ltd.,
Alfa Scientific Designs, Inc.,
Bio-Rad Laboratories, Inc.,
Medica Corporation,
Nova Biomedica.

The global point-of-care testing market is segmented on the basis of product into prescription mode, distribution channel, end user, and geography.

On the basis of product, the market is segmented into 13 major segments, which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.

Cardiometabolic Monitoring Kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections), and respiratory infections testing kit. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.

Based on prescription mode, the global point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.

On the basis of distribution channel, the market is segmented into direct tenders and retail.

On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. Hospital segment is further categorized into emergency department critical-care unit, general ward, and others (intensive care unit, neo-natal). Also, clinic is segmented into physicians’ clinic and diagnostic clinic.

 

TABLE OF CONTENTS

1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL POINT-OF-CARE TESTING MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURC
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. GROWING GERIATRIC POPULATION
3.1.2. ADVANCEMENT IN TECHNOLOGY
3.1.3. DECENTRALIZED LABORATORY TESTING
3.1.4. INCREASED INCIDENCE OF CHRONIC DISEASES
3.1.5. LABORATORY STAFF SHORTAGES
3.2. RESTRAINTS
3.2.1. UNFAVOURABLE REIMBURSEMENT SCENARIO
3.2.2. ECONOMIC COST
3.3. OPPORTUNITIES
3.3.1. EMERGING MICROFLUIDIC LAB-ON-A-CHIP TECHNOLOGY
3.3.2. EMERGING MARKETS
3.3.3. UNMET MEDICAL NEEDS
3.4. CHALLENGES
3.4.1. LACK OF ACCURACY AND EFFICIENCY
3.4.2. DATA MANAGEMENT AND LACK OF CONNECTIVITY
3.4.3. TESTING PERFORMED BY NON-LABORATORY PERSONNEL AND LACK OF AWARENESS AMONG  THE USERS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL POINT-OF-CARE TESTING MARKET: REGULATORY SCENARIO
6.1. OVERVIEW:
6.1.1. REGULATORY PROCEDURE:
7. GLOBAL POINT-OF-CARE TESTING MARKET: REIMBURSEMENT SCENARIO
7.1. OVERVIEW:
8. GLOBAL POINT-OF-CARE TESTING MARKET,  BY PRODUCT TYPE
8.1. OVERVIEW
8.2. CARDIOMETABOLIC MONITORING KITS
8.2.1. CARDIAC MARKERS
8.2.2. BLOOD GAS ELECTROLYTE TESTING KITS
8.2.3. HBA1C TESTING KITS
8.2.4. LIPID TESTING KITS
8.3. INFECTIOUS DISEASE TESTING KITS
8.3.1. INFLUENZA TESTING KITS
8.3.2. HIV TESTING KITS
8.3.3. HEPATITIS TESTING KITS
8.3.4. STD TESTING KITS
8.3.5. TROPICAL DISEASESTESTING KITS
8.3.6. HEALTHCARE ASSOCIATED TESTING KITS
8.3.7. RESPIRATORY INFECTIONS TESTING KITS
8.4. CHOLESTEROL TESTING KITS
8.4.1. PROTHROMBIN TIME TESTING KITS
8.4.2. ACTIVATED CLOTTING TIME TESTING KITS
8.5. BLOOD GLUCOSE TESTING KITS
8.6. PREGNANCY AND FERTILITY TESTING KITS
8.7. TUMOR CANCER MARKERS
8.8. URINALYSIS TESTING KITS
8.9. HEMATOLOGY TESTING KITS
8.10. DRUGS OF ABUSE TESTING KITS
8.11. FECAL OCCULT TESTING KITS
8.12. RAPID COAGULATION TESTING KITS
9. GLOBAL POINT-OF-CARE TESTING MARKET,  BY DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.1.1. DIRECT TENDER
9.1.2. RETAIL PHARMACY
10. GLOBAL POINT-OF-CARE TESTING MARKET,  BY END USER
10.1. OVERVIEW
10.2. GLOBAL POCT MARKET: HOSPITALS
10.3. GLOBAL POCT MARKET: CLINICS
10.4. GLOBAL POCT MARKET: AMBULATORY CARE
10.5. GLOBAL POCT MARKET: HOME HEALTHCARE
10.6. GLOBAL POCT MARKET: RESEARCH LABORATORIES

11. GLOBAL POINT-OF-CARE TESTING MARKET,  BY PRESCRIPTION MODE
11.1. OVERVIEW
11.2. GLOBAL POCT MARKET: PRESCRIPTION BASED TESTING KITS
11.3. GLOBAL POCT MARKET: OVER THE COUNTER BASED TESTING KITS
12. GLOBAL POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY
12.1. OVERVIEW
12.2. NORTH AMERICA POINT-OF-CARE TESTING MARKET
12.2.1. U.S.POINT-OF-CARE TESTING MARKET
12.2.2. CANADA POINT-OF-CARE TESTING MARKET
12.2.3. MEXICO POINT-OF-CARE TESTING MARKET
12.3. EUROPE POINT-OF-CARE TESTING MARKET
12.3.1. GERMANY POINT-OF-CARE TESTING MARKET
12.3.2. FRANCE POINT-OF-CARE TESTING MARKET
12.3.3. U.K. POINT-OF-CARE TESTING MARKET
12.3.4. ITALY POINT-OF-CARE TESTING MARKET
12.3.5. SPAIN POINT-OF-CARE TESTING MARKET
12.3.6. RUSSIA POINT-OF-CARE TESTING MARKET
12.3.7. TURKEY POINT-OF-CARE TESTING MARKET
12.3.8. BELGIUM POINT-OF-CARE TESTING MARKET
12.3.9. NETHERLANDS POINT-OF-CARE TESTING MARKET
12.3.10. SWITZERLAND POINT-OF-CARE TESTING MARKET
12.3.11. REST OF EUROPE POINT-OF-CARE TESTING MARKET
12.4. APAC POINT-OF-CARE TESTING MARKET
12.4.1. JAPAN POINT-OF-CARE TESTING MARKET
12.4.2. CHINA POINT-OF-CARE TESTING MARKET
12.4.3. SOUTH KOREA POINT-OF-CARE TESTING MARKET
12.4.4. INDIA POINT-OF-CARE TESTING MARKET
12.4.5. AUSTRALIA POINT-OF-CARE TESTING MARKET
12.4.6. SINGAPORE POINT-OF-CARE TESTING MARKET
12.4.7. THAILAND POINT-OF-CARE TESTING MARKET
12.4.8. MALAYSIA  POINT-OF-CARE TESTING MARKET
12.4.9. INDONESIA POINT-OF-CARE TESTING MARKET
12.4.10. PHILIPPINES POINT-OF-CARE TESTING MARKET
12.4.11. REST OF APAC POINT-OF-CARE TESTING MARKET
12.5. MEA POINT-OF-CARE TESTING MARKET
12.5.1. SOUTH AFRICA POINT-OF-CARE TESTING MARKET
12.5.2. SAUDI ARABIA POINT-OF-CARE TESTING MARKET
12.5.3. UAE POINT-OF-CARE TESTING MARKET
12.5.4. REST OF MEA POINT-OF-CARE TESTING MARKET
12.6. SOUTH AMERICA POINT-OF-CARE TESTING MARKET
12.6.1. BRAZIL POINT-OF-CARE TESTING MARKET
13. GLOBAL POINT-OF-CARE TESTING MARKET : COMPANY LANDSCAPE
13.1. COMPANY SHARE ANALYSIS: GLOBAL
13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3. COMPANY SHARE ANALYSIS: EUROPE
13.4. COMPANY SHARE ANALYSIS: APAC
14. COMPANY PROFILES
14.1. JOHNSON AND JOHNSON SERVICES, INC.
14.1.1. COMPANY OVERVIEW
14.1.2. REVENUE ANALYSIS
14.1.3. PRODUCT PORTFOLIO
14.1.4. RECENT DEVELOPMENTS
14.2. BECTON, DICKINSON AND COMPANY
14.2.1. COMPANY OVERVIEW
14.2.2. REVENUE ANALYSIS
14.2.3. PRODUCT PORTFOLIO
14.2.4. RECENT DEVELOPMENTS
14.3. MEDTRONIC
14.3.1. COMPANY OVERVIEW
14.3.2. REVENUE ANALYSIS
14.3.3. PRODUCT PORTFOLIO
14.3.4. RECENT DEVELOPMENTS
14.4. F. HOFFMANN-LA ROCHE LTD
14.4.1. COMPANY OVERVIEW
14.4.2. REVENUE ANALYSIS
14.4.3. PRODUCT PORTFOLIO
14.4.4. RECENT DEVELOPMENTS
14.5. SIEMENS AG
14.5.1. COMPANY OVERVIEW
14.5.2. REVENUE ANALYSIS
14.5.3. PRODUCT PORTFOLIO
14.5.4. RECENT DEVELOPMENTS
14.6. ABBOTT
14.6.1. COMPANY OVERVIEW
14.6.2. REVENUE ANALYSIS
14.6.3. PRODUCT PORTFOLIO
14.6.4. PRODUCT PIPELINE
14.6.5. RECENT DEVELOPMENTS
14.7. DANAHER
14.7.1. COMPANY OVERVIEW
14.7.2. REVENUE ANALYSIS
14.7.3. PRODUCT PORTFOLIO
14.7.4. RECENT DEVELOPMENTS
14.8. WERFENLIFE
14.8.1. COMPANY OVERVIEW
14.8.2. REVENUE ANALYSIS
14.8.3. PRODUCT PORTFOLIO
14.8.4. RECENT DEVELOPMENTS
14.9. HENRY SCHEIN, INC.
14.9.1. COMPANY OVERVIEW
14.9.2. REVENUE ANALYSIS
14.9.3. PRODUCT PORTFOLIO
14.9.4. RECENT DEVELOPMENTS
14.10. OPTI MEDICAL (SUBSIDIARY OF IDEXX LABORATORIES, INC)
14.10.1. COMPANY OVERVIEW
14.10.2. REVENUE ANALYSIS
14.10.3. PRODUCT PORTFOLIO
14.10.4. RECENT DEVELOPMENTS
14.11. SIENCO, INC.
14.11.1. COMPANY OVERVIEW
14.11.2. REVENUE ANALYSIS
14.11.3. PRODUCT PORTFOLIO
14.11.4. RECENT DEVELOPMENTS
14.12. ACON LABORATORIES, INC.
14.12.1. COMPANY OVERVIEW
14.12.2. REVENUE ANALYSIS
14.12.3. PRODUCT PORTFOLIO
14.12.4. RECENT DEVELOPMENTS
14.13. ATIVA MEDICAL CORPORATION
14.13.1. COMPANY OVERVIEW
14.13.2. REVENUE ANALYSIS
14.13.3. PRODUCT PORTFOLIO
14.13.4. RECENT DEVELOPMENTS
14.14. ABAXIS
14.14.1. COMPANY OVERVIEW
14.14.2. REVENUE ANALYSIS
14.14.3. PRODUCT PORTFOLIO
14.14.4. RECENT DEVELOPMENTS
14.15. ARKRAY, INC
14.15.1. COMPANY OVERVIEW
14.15.2. REVENUE ANALYSIS
14.15.3. PRODUCT PORTFOLIO
14.15.4. RECENT DEVELOPMENTS
14.16. AERSCHER DIAGNOSTICS, LLC
14.16.1. COMPANY OVERVIEW
14.16.2. REVENUE ANALYSIS
14.16.3. PRODUCT PORTFOLIO
14.16.4. RECENT DEVELOPMENTS
14.17. ARTRON LABORATORIES, INC.
14.17.1. COMPANY OVERVIEW
14.17.2. REVENUE ANALYSIS
14.17.3. PRODUCT PORTFOLIO
14.17.4. RECENT DEVELOPMENTS
14.18. BIOMERIEUX SA
14.18.1. COMPANY OVERVIEW
14.18.2. REVENUE ANALYSIS
14.18.3. PRODUCT PORTFOLIO
14.18.4. RECENT DEVELOPMENTS
14.19. ENTOPSIS
14.19.1. COMPANY OVERVIEW
14.19.2. REVENUE ANALYSIS
14.19.3. PRODUCT PORTFOLIO
14.19.4. RECENT DEVELOPMENTS
14.20. LIFESIGN, LLC.
14.20.1. COMPANY OVERVIEW
14.20.2. REVENUE ANALYSIS
14.20.3. PRODUCT PORTFOLIO
14.20.4. RECENT DEVELOPMENTS
15. RELATED REPORTS

 




TABLE LIST
TABLE 1  LIST OF DIFFERENT TYPES OF APPROVAL FOR DIFFERENT COUNTRIES
TABLE 2  GLOBAL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 3  GLOBAL CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING MARKET, BY  TYPE, 2015 – 2024 (USD MILLION)
TABLE 4  GLOBAL INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 5  GLOBAL CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 6  GLOBAL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
TABLE 7  DISTRIBUTION CHANNEL, DIRECT TENDER, BY REGION, 2015 – 2024 (USD MILLION)
TABLE 8  DISTRIBUTION CHANNEL, RETAIL PHARMACY, BY REGION, 2015 – 2024 (USD MILLION)
TABLE 9  GLOBAL POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 10  GLOBAL POINT-OF-CARE TESTING MARKET, HOSPITALS, BY REGION 2015– 2024 (USD MILLION)
TABLE 11  GLOBAL POINT-OF-CARE TESTING MARKET, CLINICS, BY REGION 2015– 2024 (USD MILLION)
TABLE 12  GLOBAL POINT-OF-CARE TESTING MARKET, AMBULATORY CARE, BY REGION 2015– 2024 (USD MILLION)
TABLE 13  GLOBAL POINT-OF-CARE TESTING MARKET, HOME HEALTHCARE, BY REGION 2015– 2024 (USD MILLION)
TABLE 14  GLOBAL POINT-OF-CARE TESTING MARKET, RESEARCH LABORATORY, BY REGION 2015– 2024 (USD MILLION)
TABLE 15  GLOBAL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015– 2024 (USD MILLION)
TABLE 16  GLOBAL POINT-OF-CARE TESTING MARKET, PRESCRIPTION BASED TESTING KITS, BY REGION, 2015– 2024 (USD MILLION)
TABLE 17  GLOBAL POINT-OF-CARE TESTING MARKET, OVER THE COUNTER BASED TESTING KITS, BY REGION, 2015– 2024 (USD MILLION)
TABLE 18  GLOBAL POINT-OF-CARE TESTING  MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION)
TABLE 19  NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024  (USD MILLION)
TABLE 20  NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 21  NORTH AMERICA CARDIOMETABOLIC MONITORING  POINT-OF-CARE TESTING  MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 22  NORTH AMERICA INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 23  NORTH AMERICA CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 24  NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE 2015 – 2024 (USD MILLION)
TABLE 25  NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 26  NORTH AMERICA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 27  U.S.POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 28  U.S. POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 29  U.S. POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 30  U.S. POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 31  CANADA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 32  CANADA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 33  CANADA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 34  CANADA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 35  MEXICO POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 36  MEXICO POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 37  MEXICO POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 38  MEXICO POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 39  EUROPE POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024  (USD MILLION)
TABLE 40  EUROPE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 41  EUROPE CARDIOMETABOLIC MONITORING  POINT-OF-CARE TESTING  MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 42  EUROPE INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 43  EUROPE CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 44  EUROPE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE  2015 – 2024 (USD MILLION)
TABLE 45  EUROPE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 46  EUROPE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 47  GERMANY  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 48  GERMANY  POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE 2015 – 2024 (USD MILLION)
TABLE 49  GERMANY  POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 50  GERMANY  POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 51  FRANCE  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 52  FRANCE  POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION)
TABLE 53  FRANCE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 54  FRANCE  POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 55  U.K. POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 56  U.K. POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 57  U.K. POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 58  U.K. POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 59  ITALY  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 60  ITALY POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 61  ITALY POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 62  ITALY POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 63  SPAIN  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 64  SPAIN  POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 65  SPAIN  POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 66  SPAIN POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 67  RUSSIA  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 68  RUSSIA  POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 69  RUSSIA  POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 70  RUSSIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 71  TURKEY POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 72  TURKEY POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 73  TURKEY POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 74  TURKEY POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 75  BELGIUM POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 76  BELGIUM POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 77  BELGIUM  POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 78  BELGIUM POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 79  NETHERLANDS  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 80  NETHERLANDS  POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 81  NETHERLANDS POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 82  NETHERLANDS POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 83  SWITZERLAND  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 84  SWITZERLAND  POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 85  SWITZERLAND POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 86  SWITZERLAND POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015–2024 (USD MILLION)
TABLE 87  REST OF EUROPE  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 88  APAC POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 89  APAC POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 90  APAC  CARDIOMETABOLIC MONITORING  POINT-OF-CARE TESTING  MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 91  APAC INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 92  APAC  CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 93  APAC POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 94  APAC  POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 95  APAC POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL , 2015– 2024 (USD MILLION)
TABLE 96  JAPAN  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 97  JAPAN  POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION)
TABLE 98  JAPAN POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 99  JAPAN POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 100  CHINA  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 101  CHINA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION)
TABLE 102  CHINA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 103  CHINA  POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 104  SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY PRODUCT  TYPE, 2015 – 2024 (USD MILLION)
TABLE 105  SOUTH KOREA  POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 106  SOUTH KOREA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 107  SOUTH KOREA  POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 108  INDIA  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 109  INDIA  POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 110  INDIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 111  INDIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL , 2015– 2024 (USD MILLION)
TABLE 112  AUSTRALIA  POINT-OF-CARE TESTING MARKET, BY PRODUCT  TYPE, 2015 – 2024 (USD MILLION)
TABLE 113  AUSTRALIA  POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 114  AUSTRALIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 115  AUSTRALIA  POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 116  SINGAPORE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 117  SINGAPORE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 118  SINGAPORE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 119  SINGAPORE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 120  THAILAND POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 121  THAILAND POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 122  THAILAND POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 123  THAILAND POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 124  MALAYSIA  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 125  MALAYSIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 126  MALAYSIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 127  MALAYSIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 128  INDONESIA  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 129  INDONESIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 130  INDONESIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 131  INDONESIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 132  PHILIPPINES POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 133  PHILIPPINES POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 134  PHILIPPINES POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 135  PHILIPPINES POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 136  REST OF APAC  POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 137  MEA POINT-OF-CARE TESTING MARKET, BY COUNTRY, 2015 – 2024  (USD MILLION)
TABLE 138  MEA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 139  MEA CARDIOMETABOLIC MONITORING  POINT-OF-CARE TESTING  MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 140  MEA INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY PRODUCT  TYPE,2015 – 2024 (USD MILLION)
TABLE 141  MEA CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 142  MEA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 143  MEA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 144  MEA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 145  SOUTH AFRICA  POINT-OF-CARE TESTING MARKET, BY PRODUCT  TYPE, 2015 – 2024 (USD MILLION)
TABLE 146  SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 147  SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 148  SOUTH AFRICA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015–2024 (USD MILLION)
TABLE 149  SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 150  SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 151  SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 152  SAUDI ARABIA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 153  UAE POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 154  UAE POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE , 2015 – 2024 (USD MILLION)
TABLE 155  UAE POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 156  UAE POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
TABLE 157  REST OF MEA POINT-OF-CARE TESTING MARKET, BY PRODUCTTYPE, 2015 – 2024 (USD MILLION)
TABLE 158  SOUTH AMERICA: HEALTHCARE SPENDING (USD PER HEAD)
TABLE 159  SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY COUNTRY,2015 – 2024  (USD MILLION)
TABLE 160  SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 161  SOUTH AMERICA CARDIOMETABOLIC MONITORING POINT-OF-CARE TESTING  MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 162  SOUTH AMERICA INFECTIOUS DISEASE POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 163  SOUTH AMERICA CHOLESTEROL POINT-OF-CARE TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 164  SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 165  SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY END-USER, 2015 – 2024  (USD MILLION)
TABLE 166  SOUTH AMERICA POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL,  2015– 2024 (USD MILLION)
TABLE 167  BRAZIL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 168  BRAZIL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION)
TABLE 169  BRAZIL POINT-OF-CARE TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 170  BRAZIL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)

 

FIGURES LIST
FIGURE 1  GLOBAL POINT-OF-CARE TESTING MARKET: SEGMENTATION
FIGURE 2  GLOBAL POINT-OF-CARE TESTING MARKET: GEOGRAPHIC SCOPE
FIGURE 3  GLOBAL POINT-OF-CARE TESTING MARKET: DATA TRIANGULATION
FIGURE 4  GLOBAL POINT-OF-CARE TESTING MARKET RESEARCH SNAPSHOT
FIGURE 5  GLOBAL POINT-OF-CARE TESTING MARKET  BOTTOM UP APPROACH
FIGURE 6  GLOBAL POINT-OF-CARE TESTING MARKET TOP DOWN APPROACH
FIGURE 7  GLOBAL POINT-OF-CARE TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8  DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE POINT-OF-CARE TESTING MARKET
FIGURE 9  GLOBAL POINT-OF-CARE TESTING MARKET: SEGMENTATION
FIGURE 10  NORTH AMERICA IS EXPECTED TO DOMINATE THE MARKET FOR POINT-OF-CARE TESTINGIN 2016 AND APAC IS EXPECTED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST  PERIOD TO 2024
FIGURE 11  HIGH PREVALANCE OF INFECTIOUS DISEASES ARE EXPECTED TO DRIVE THE MARKET FOR POINT-OF-CARE TESTING IN THE FORECAST PERIOD 2017 TO 2024
FIGURE 12  BLOOD GLUCOSE TESTING MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE POINT-OF-CARE TESTING MARKET IN 2017 & 2024
FIGURE 13  NORTH AMERICA IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR POINT-OF-CARE TESTING MANUFACTURERS IN THE FORECAST PERIOD TO 2024
FIGURE 14  GLOBAL POINT-OF-CARE TESTING MARKET:  BY TYPE, SNAPSHOT 2016
FIGURE 15  GLOBAL POCT MARKET: CARDIOMETABOLIC MONITORING KITS MARKET: BY REGION
FIGURE 16  GLOBAL POCT MARKET: INFECTIOUS DISEASE TESTING KITS MARKET: BY REGION
FIGURE 17  GLOBAL POCT MARKET: CHOLESTROL TESTING KITS MARKET:  BY REGION
FIGURE 18  GLOBAL POCT MARKET: BLOOD GLUCOSE TESTING KITS MARKET:  BY REGION
FIGURE 19  GLOBAL POCT MARKET: PREGNANCY AND FERTILITY TESTING KITS MARKET: BY REGION
FIGURE 20  GLOBAL POCT MARKET: TUMOR CANCER MARKERS MARKET:  BY REGION
FIGURE 21  GLOBAL POCT MARKET: URINALYSIS TESTING KITS MARKET: BY REGION
FIGURE 22  GLOBAL POCT MARKET: HEMATOLOGY TESTING KITS MARKET: BY REGION
FIGURE 23  GLOBAL POCT MARKET: DRUGS OF ABUSE TESTING KITS MARKET: BY REGION
FIGURE 24  GLOBAL POCT MARKET: FECAL OCCULT TESTING KITS MARKET:  BY REGION
FIGURE 25  GLOBAL POCT MARKET: RAPID COAGULATION TESTING KITSMARKET: BY REGION
FIGURE 26  GLOBAL POINT-OF-CARE TESTING MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
FIGURE 27  GLOBAL POCT MARKET: DIRECT TENDER MARKET: BY REGION
FIGURE 28  RETAIL PHARMACY MARKET: BY REGION
FIGURE 29  GLOBAL POINT-OF-CARE TESTING MARKET DOMINATED  BY HOSPITALS SEGMENT
FIGURE 30  GLOBAL POINT-OF-CARE TESTING MARKET:BY END-USER, SNAPSHOT 2016
FIGURE 31  GLOBAL POCT MARKET: HOSPITALS; BY REGION
FIGURE 32  GLOBAL POCT MARKET: CLINICS; BY REGION
FIGURE 33  GLOBAL POCT MARKET: AMBULATORY CARE; B
FIGURE 34  GLOBAL POCT MARKET: HOME HEALTHCARE; BY REGION
FIGURE 35  GLOBAL POCT MARKET: RESEARCH LABORATORY; BY REGION
FIGURE 36  GLOBAL POINT-OF-CARE TESTING MARKET:BY PRESCRIPTION MODE, SNAPSHOT 2016
FIGURE 37  GLOBAL POCT MARKET: PRESCRIPTION BASED TESTING KITS;  BY REGION
FIGURE 38  GLOBAL POCT MARKET: OVER THE COUNTER BASED TESTING KITS; BY REGION
FIGURE 39  NORTH AMERICA POINT-OF-CARE TESTING MARKET  SNAPSHOT (2017)
FIGURE 40  NORTH AMERICA POINT-OF-CARE TESTING MARKET : BY COUNTRY (2017)
FIGURE 41  NORTH AMERICA POINT-OF-CARE TESTING MARKET  BY COUNTRY (2016 & 2024)
FIGURE 42  NORTH AMERICA POINT-OF-CARE TESTING MARKET  BY PRODUCT TYPE (2017 & 2024)
FIGURE 43  EUROPEPOINT-OF-CARE TESTING MARKET  SNAPSHOT (2017)
FIGURE 44  EUROPEPOINT-OF-CARE TESTING MARKET  BY COUNTRY (2017)
FIGURE 45  EUROPE POINT-OF-CARE TESTING MARKET  BY COUNTRY (2016 & 2024)
FIGURE 46  EUROPEPOINT-OF-CARE TESTING MARKET  BY PRODUCT TYPE (2017 & 2024)
FIGURE 47  APACPOINT-OF-CARE TESTING MARKET : SNAPSHOT (2017)
FIGURE 48  APACPOINT-OF-CARE TESTING MARKET : BY COUNTRY (2017)
FIGURE 49  APAC POINT-OF-CARE TESTING MARKET :BY PRODUCT TYPE  (2016 & 2024)
FIGURE 50  MEA POINT-OF-CARE TESTING MARKET: SNAPSHOT (2017)
FIGURE 51  MEA POINT-OF-CARE TESTING MARKET: BY COUNTRY (2017
FIGURE 52  MEA POINT-OF-CARE TESTING MARKET:BY PRODUCT TYPE  (2016 & 2024)
FIGURE 53  SOUTH AMERICAPOINT-OF-CARE TESTING MARKET :  SNAPSHOT (2017)
FIGURE 54  SOUTH AMERICAPOINT-OF-CARE TESTING MARKET :  BY COUNTRY (2017)
FIGURE 55  SOUTH AMERICA POINT-OF-CARE TESTING MARKET : BY PRODUCT TYPE (2016 & 2024)
FIGURE 56  GLOBAL POINT-OF-CARE TESTING MARKET:  COMPANY SHARE 2016 (%)
FIGURE 57  NORTH AMERICA POINT-OF-CARE TESTING MARKET:  COMPANY SHARE 2016 (%)
FIGURE 58  EUROPE POINT-OF-CARE TESTING MARKET:  COMPANY SHARE 2016 (%)
FIGURE 59  APAC POINT-OF-CARE TESTING MARKET:  COMPANY SHARE 2016 (%)